Literature DB >> 19273284

Neutrophil-derived serine proteases modulate innate immune responses.

Ulf Meyer-Hoffert1.   

Abstract

The serine proteases cathepsin G, human leukocyte elastase and proteinase 3 are major contents of neutrophil granulocytes and are released at sites of inflammation. Although the traditional function of neutrophil-derived antimicrobial proteases is to ingest and kill bacteria, recent studies provided evidence that these proteases are able to activate specifically pro-inflammatory cytokines including interleukin-1 beta and TNF-alpha and lead to the activation of different receptors including epidermal growth factor receptor and proteinase-activated receptors. Neutrophil serine proteases might therefore be important regulators of the inflammatory innate immune response and are interesting targets for new therapeutic approaches against inflammatory disorders. This review summarizes the current knowledge on the molecular regulation of the innate immune response by neutrophil-derived serine proteases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273284     DOI: 10.2741/3462

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  29 in total

Review 1.  Neutrophils in periodontal inflammation.

Authors:  David A Scott; Jennifer Krauss
Journal:  Front Oral Biol       Date:  2011-11-11

2.  ANTI-INFECTIVE PROTECTIVE PROPERTIES OF S100 CALGRANULINS.

Authors:  Kenneth Hsu; Chantrakorn Champaiboon; Brian D Guenther; Brent S Sorenson; Ali Khammanivong; Karen F Ross; Carolyn L Geczy; Mark C Herzberg
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2009-12-04

Review 3.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 4.  Contribution of neutrophils to acute lung injury.

Authors:  Jochen Grommes; Oliver Soehnlein
Journal:  Mol Med       Date:  2010-10-18       Impact factor: 6.354

5.  [Interleukin-1 cytokines, inflammasomes, NOD-signalosomes and autoinflammation].

Authors:  S D Gadola
Journal:  Z Rheumatol       Date:  2009-11       Impact factor: 1.372

6.  Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation.

Authors:  Tian-Hui Yang; Lisa S St John; Haven R Garber; Celine Kerros; Kathryn E Ruisaard; Karen Clise-Dwyer; Gheath Alatrash; Qing Ma; Jeffrey J Molldrem
Journal:  J Immunol       Date:  2018-07-18       Impact factor: 5.422

7.  Neutrophil elastase acts as a biased agonist for proteinase-activated receptor-2 (PAR2).

Authors:  Rithwik Ramachandran; Koichiro Mihara; Hyunjae Chung; Bernard Renaux; Chang S Lau; Daniel A Muruve; Kathryn A DeFea; Michel Bouvier; Morley D Hollenberg
Journal:  J Biol Chem       Date:  2011-05-16       Impact factor: 5.157

8.  Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus.

Authors:  Eneida Villanueva; Srilakshmi Yalavarthi; Celine C Berthier; Jeffrey B Hodgin; Ritika Khandpur; Andrew M Lin; Cory J Rubin; Wenpu Zhao; Stephen H Olsen; Matthew Klinker; David Shealy; Michael F Denny; Joel Plumas; Laurence Chaperot; Matthias Kretzler; Allen T Bruce; Mariana J Kaplan
Journal:  J Immunol       Date:  2011-05-25       Impact factor: 5.422

Review 9.  Neutrophil elastase inhibitors.

Authors:  William C Groutas; Dengfeng Dou; Kevin R Alliston
Journal:  Expert Opin Ther Pat       Date:  2011-01-16       Impact factor: 6.674

10.  Interleukin-1 Receptor 1 Deletion in Focal and Diffuse Experimental Traumatic Brain Injury in Mice.

Authors:  Joon Yong Chung; Nicolas Krapp; Limin Wu; Sevda Lule; Lauren M McAllister; William J Edmiston; Samantha Martin; Emily Levy; Tanya Songtachalert; John S Sherwood; Erin M Buckley; Bharat Sanders; Saef Izzy; Suzanne Hickman; Shuzhen Guo; Josephine Lok; Joseph El Khoury; Eng H Lo; David Kaplan; Michael J Whalen
Journal:  J Neurotrauma       Date:  2018-08-03       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.